M1417 HCPCS Level II code: Patients who are up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination
M1417 is the HCPCS code for “Patients who are up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
M1417Patients who are up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination
Short description: Pt up to date cov
HCPCS · United States
Medicare details
The indicators CMS publishes with M1417 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Undefined codes
- Added
- Jan 1, 2025
Where M1417 sits
- 1M codesMedical services and quality measures
- 2Active code M1417Patients who are up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code M1417 mean?
M1417 is the HCPCS code for “Patients who are up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover M1417?
CMS lists M1417’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside M1417
All M codesM1411Currently on first-line immune checkpoint inhibitors without chemotherapyM1412Patients with metastatic nsclc with epidermal growth factor receptor (egfr) mutations, alk genomic tumor aberrations, or other targetable genomic abnormalities with approved…M1413Patients who had a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapyM1414Documentation of medical reason(s) for not performing the pd-l1 biomarker expression test prior to initiation of first-line immune checkpoint inhibitor therapy (e.g., patient is…M1415Patients who did not have a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapyM1416Patient received hospice services any time during the performance periodM1418Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination because of a medical contraindication documented by…M1419Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccinationM1420Complete ophthalmologic care mips value pathwayM1421Dermatological care mips value pathwayM1422Gastroenterology care mips value pathwayM1423Optimal care for patients with urologic conditions mips value pathway